Wells Fargo
TNGX icon

Wells Fargo’s Tango Therapeutics TNGX Stock Holding History

Wells Fargo’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$878K Sell
41,972
-79,214
-65% -$1.1M ﹤0.01% 3811
2025
Q4 		$1.07M Buy
121,186
+66,181
+120% +$570K ﹤0.01% 3914
2025
Q3 		$462K Buy
55,005
+5,788
+12% +$39.2K ﹤0.01% 4361
2025
Q2 		$252K Buy
49,217
+26,422
+116% +$65.3K ﹤0.01% 4634
2025
Q1 		$31.2K Buy
22,795
+503
+2% +$1.24K ﹤0.01% 5552
2024
Q4 		$68.9K Buy
22,292
+7,599
+52% +$35.3K ﹤0.01% 5384
2024
Q3 		$113K Sell
14,693
-581
-4% -$5.54K ﹤0.01% 4940
2024
Q2 		$131K Sell
15,274
-539
-3% -$4.17K ﹤0.01% 4778
2024
Q1 		$126K Buy
15,813
+2,025
+15% +$21.7K ﹤0.01% 4762
2023
Q4 		$137K Buy
13,788
+2,717
+25% +$23.6K ﹤0.01% 4711
2023
Q3 		$125K Sell
11,071
-5,928
-35% -$36.1K ﹤0.01% 4650
2023
Q2 		$56.4K Buy
16,999
+8,731
+106% +$31.4K ﹤0.01% 5380
2023
Q1 		$32.7K Buy
+8,268
New +$48K ﹤0.01% 5395
2022
Q4 		– Sell
-96
Closed – – 7729
2022
Q3 		$0 Sell
96
-613
-86% -$2.62K ﹤0.01% 7369
2022
Q2 		$3K Buy
709
+316
+80% +$1.91K ﹤0.01% 6229
2022
Q1 		$3K Buy
393
+1
+0.3% +$9 ﹤0.01% 6602
2021
Q4 		$4K Buy
392
+1
+0.3% +$12 ﹤0.01% 6767
2021
Q3 		$5K Buy
+391
New +$4.69K ﹤0.01% 6386
2021
Q1 		– Sell
-8,568
Closed -$98K – 7374
2020
Q4 		$98K Buy
+8,568
New +$90.2K ﹤0.01% 5369

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Wells Fargo's TNGX Position: Q1 2026 in Review

Wells Fargo reduced its Tango Therapeutics (TNGX) stake by 65% in Q1 2026, selling an estimated $1.1M and leaving 41,972 shares worth $878K. The position accounts for ﹤0.01% of the portfolio, ranked #3811.

Wells Fargo first reported a position in TNGX in Q4 2020 and has held it in 19 quarters since. The position peaked at $1.07M in Q4 2025. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Wells Fargo held 41,972 shares of Tango Therapeutics worth $878K as of Q1 2026.
  • Wells Fargo sold 79,214 Tango Therapeutics shares in Q1 2026, an estimated $1.1M.
  • Tango Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3811 holding.
  • Wells Fargo first reported a position in Tango Therapeutics in Q4 2020 and has held it in 19 quarters since.
  • Wells Fargo's Tango Therapeutics position peaked at $1.07M in Q4 2025.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.